Stocks:
5,168
ETFs:
2,288
Exchanges:
11
Market Cap:
$65.78T
24h Vol:
$10.16B
Dominance:
MSFT:4.81%
Stocklytics Platform
Asset logo  ATRI
Atrion
ATRI
55 / 100
$451.25arrow_drop_down4.47%-$21.14

Performance History

Stocklytics logo
Key Stats
Open$473.00
Prev. Close$472.39
EPS10.63
Dividend$8.75
Next Earnings DateJul 12, 2024
Dividend Yield %1.86%
Market Cap$829.58M
PE Ratio42.45
LOWHIGH
Day Range450.00
473.00
52 Week Range274.98
602.59
Ratios
P/B Ratio2.89
Revenue$169.32M
Operating M. %11.50%
Earnings$19.41M
Earnings Growth %-44.55%
EBITDA Margin %23.08%
ROE %7.79%
EPS10.63

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$803.16
24H (%)arrow_drop_up2.55%
24H ($)$19.98
MARKET CAP$744.33B
PRICE$523.54
24H (%)arrow_drop_up1.22%
24H ($)$6.32
MARKET CAP$476.05B
PRICE$151.24
24H (%)arrow_drop_down0.01%
24H ($)-$0.03
MARKET CAP$364.05B
PRICE$130.75
24H (%)arrow_drop_down0.17%
24H ($)-$0.23
MARKET CAP$332.27B

About Atrion (ATRI)

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of specialized medical devices that include disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Mr. David A. Battat
Headquarters
Allen
Employees
722
Exchange
NASDAQ
add Atrion to watchlist

Keep an eye on Atrion

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is the market capitalization of Atrion (ATRI)?

Atrion (ATRI) has a market capitalization of $829.59M. The average daily trading volume is 32.69K, indicating the stock's liquidity and investor engagement.

help
What is Atrion's (ATRI) price per share?

The current price per share for Atrion (ATRI) is $451.25. The stock has seen a price change of -$21.15 recently, indicating a -4.48% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Atrion (ATRI)?

For Atrion (ATRI), the 52-week high is $602.59, which is 33.54% from the current price. The 52-week low is $274.98, the current price is 64.1% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Atrion (ATRI) a growth stock?

Atrion (ATRI) has shown an average price growth of 0.41% over the past three years. It has received a score of 36 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Atrion as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Atrion (ATRI) stock price performance year to date (YTD)?

As of the latest data, Atrion (ATRI) has a year-to-date price change of 14.75%. Over the past month, the stock has experienced a price change of 12.86%. Over the last three months, the change has been 24.36%. Over the past six months, the figure is 54.38%. Looking at a longer horizon, the five-year price change stands at -50.63%.

help
Is Atrion (ATRI) a profitable company?

Atrion (ATRI) has a net income of $19.41M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 36.84% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 11.5% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $169.33M, although specific revenue growth data is currently not available. The gross profit is $62.39M. Operating income is noted at $22.58M. Furthermore, the EBITDA is $37.49M.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level